More than 280 million people live with depression, according to the World Health Organization. People experience the ...

Synbio International Inc. secures rights to conduct clinical trials for AI-powered depression screening technology (NIMS: Non ...

Treatment-resistant depression complicates care, defying standard treatments, but new therapies are on the horizon, offering hope for more effective treatment options.

Though girls reported greater depression and anxiety symptoms, there were generally no health inequities at inpatient psychiatric unit discharge.

Psilocybin therapy significantly decreased moderate to severe symptoms of depression in clinicians after frontline work ...

Announcing a new publication for Acta Materia Medica journal. The prevalence of depressive-like behavior is significantly ...

Some studies link GLP-1 drugs for diabetes with neuroprotective benefits but others say that some of these drugs may increase ...

A digital-based therapy using a mobile application with recording and analytic functions can relieve symptoms of insomnia and ...

Compared to other diabetes medications, GLP-1 drugs like Ozempic were associated with a lower risk for depression in a recent study.

The Alzheimer's Association revised the diagnostic criteria for Alzheimer disease (AD) and ADRD for clinicians in primary and specialty care.

Synbio International Inc. secures rights to conduct clinical trials for AI-powered depression screening technology (NIMS: Non-invasive Mental Screening).NIMS is a fast, highly accurate and cost-effect ...

Identifying and treating risk factors for depression, anxiety and other psychological health conditions during pregnancy and postpartum may improve short- and long-term health outcomes for both mother ...